Subjects n | 6 | 15 | |
Age years | 40 (26–64) | 65 (33–81) | ns |
Females | 50% | 70% | ns |
Asthma control | NA | 22% | NA |
Exacerbations in the last year | NA | 2.5 (0–12) | NA |
Best FEV1 % predicted | 100 (98–105) | 82.5 (64–100) | 0.004 |
Blood eosinophils per mm3 | 160 (130–220) | 100 (40–600) | ns |
Atopy# | 0% | 50% | 0.04 |
Sinusitis | 0% | 70% | 0.006 |
GORD | 0% | 60% | 0.016 |
At least one comorbid condition¶ | 16.7% | 66.7% | ns |
Long-term OCS | 0% | 70% | 0.006 |